Update: 50 Percent of Patients in New Brain Cancer Study Alive After Five Years
Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain ...
https://downf33d.blogspot.com/2013/11/update-50-percent-of-patients-in-new.html
Eight of 16 patients participating in a study of an experimental immune system therapy directed against the most aggressive malignant brain tumors -- glioblastoma multiforme -- survived longer than five years after diagnosis, according to Cedars-Sinai researchers, who presented findings Nov. 23 at the Fourth Quadrennial Meeting of the World Federation of Neuro-Oncology.
From Science Daily